mAB production: Step 7 – Cation Exchange Chromatography: The First Polishing Step

How we use electrostatic interactions to remove aggregates, leached Protein A, HCPs, and DNA after viral inactivation.

Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In Step 6, we performed low pH viral inactivation on the Protein A eluate, then neutralized the pool to pH 5.0–6.0. The resulting material is >95% pure, but it still contains low levels of critical impurities:

• Aggregates (dimers and higher order species)

• Leached Protein A (from the capture resin)

• Residual HCPs (host cell proteins)

• Residual DNA

• Potential viruses (non‑enveloped, not inactivated by low pH)

Now we enter the polishing chromatography phase – typically two orthogonal steps: Cation Exchange (CEX) followed by Anion Exchange (AEX) . Step 7 covers CEX, the workhorse for aggregate removal.

Let’s dive into the principles, step‑by‑step operation, critical parameters, and troubleshooting.

Overview: What Is Cation Exchange Chromatography?

Principle: CEX separates proteins based on their net positive charge. The resin contains negatively charged functional groups (e.g., sulfopropyl (SP), carboxymethyl (CM), or sulfonate (S)) that bind positively charged proteins. Impurities with different charge profiles are washed away, and the mAb is eluted by increasing salt concentration or pH.

Why CEX for mAb polishing?

• Most IgG1 antibodies have a basic isoelectric point (pI) of 7.5–9.0.

• At the typical load pH of 5.0–6.0, the mAb is positively charged (net charge +5 to +15).

• Aggregates often have slightly different charge distribution and can be separated from monomers.

• Leached Protein A (pI ~4.5–5.0) is negatively charged at pH 5.0–6.0 and flows through or binds weakly.

Operating modes:

For a standard mAb process, bind‑elute CEX is the dominant choice.

Step 7.1: Column Packing and Qualification

Similar to Protein A, the CEX column must be packed and qualified before use.

Resin selection:

Column packing: Same principles as Step 5 (Protein A). Bed height typically 15–25 cm. HETP and asymmetry tests are required.

Sanitization and storage: 0.5–1.0 M NaOH (30 min), then store in 0.1 M NaOH or 20% ethanol.

Step 7.2: The CEX Cycle – Step by Step

A typical bind‑elute CEX run takes 2–4 hours and follows these steps.

Step 7.2.1: Conditioning (Pre‑equilibration)

Purpose: Remove storage solution and sanitizing agent.

Buffer: Water for injection (WFI) or 50 mM Tris, pH 7.0 (low salt)

Volume: 2–3 CV

Step 7.2.2: Equilibration

Purpose: Set the column to the correct pH and conductivity for binding.

Buffer: 20–50 mM sodium acetate or citrate, pH 5.0–5.5 (sometimes with 10–50 mM NaCl to moderate binding)

Volume: 5–10 CV (until pH and conductivity are stable)

Critical: Conductivity should be ≤5–8 mS/cm. Higher salt weakens binding.

Step 7.2.3: Load (Binding)

Purpose: Bind the mAb to the resin while impurities flow through.

Load conditions:

• Load pH: Same as equilibration (5.0–5.5). If the viral inactivated pool is at pH 6.0, adjust with dilute acetic acid before loading.

• Load conductivity: ≤5 mS/cm (dilute with WFI if needed).

• Load density: 50–100 g mAb per liter of resin (typically 80% of dynamic binding capacity).

• Flow rate: 100–300 cm/h (2–5 min residence time).

Monitoring: UV (A280) – the mAb binds, so the UV signal drops. Breakthrough occurs when resin nears saturation.

Step 7.2.4: Wash (Post‑Load)

Purpose: Remove loosely bound impurities (HCPs, DNA, leached Protein A).

Wash 1 (low salt): Equilibration buffer (5–10 CV) – removes unbound material.

Wash 2 (intermediate salt – optional): 5–10 CV of 20–50 mM acetate + 50–100 mM NaCl, pH 5.0–5.5. This elutes some weakly bound impurities without eluting the mAb.

Wash 3 (high pH – optional): Some processes use a pH step wash (e.g., 20 mM Tris, pH 7.0) to remove more HCPs before elution.

Step 7.2.5: Elution

Purpose: Release the mAb from the resin, typically using a linear salt gradient or step elution.

Gradient elution (preferred for aggregate separation):

• Buffer A: 20–50 mM sodium acetate, pH 5.0–5.5 (low salt)

• Buffer B: Buffer A + 0.5–1.0 M NaCl (high salt)

• Gradient: 0–50% B over 10–20 CV (or 0–300 mM NaCl over 15 CV)

• Flow rate: 100–200 cm/h

Step elution (simpler, less resolution):

• Elute with 20–50 mM acetate + 150–300 mM NaCl, pH 5.0–5.5 (single step)

Peak collection: Collect based on UV (A280) threshold. The mAb elutes as a peak; aggregates (more hydrophobic or differently charged) often elute slightly earlier or later. By collecting a cut (e.g., start at 50% peak height, end at 10% on descending side), you exclude aggregates.

Typical eluate characteristics:

• mAb concentration: 2–10 g/L (diluted relative to load)

• Aggregate reduction: from 2–5% to <0.5–1%

• HCP reduction: additional 10–100×

• Leached Protein A: typically below detection

Step 7.2.6: Clean‑In‑Place (CIP)

Purpose: Remove tightly bound impurities and sanitize.

CIP protocol:

• 0.5–1.0 M NaOH, contact time 30–60 min

• Followed by WFI wash until pH <8.0

• Storage in 0.1 M NaOH or 20% ethanol

Frequency: After each cycle or daily.

Step 7.3: Critical Process Parameters (CPPs)

Step 7.4: Equipment and Scale Considerations

Chromatography skid: Same as for Protein A (Step 5), but must be compatible with the higher salt concentrations used in elution (e.g., up to 1 M NaCl). Stainless steel or single‑use flow paths are fine.

Column hardware: Stainless steel or glass. Single‑use columns (e.g., Repligen OPUS) are increasingly used for polishing to avoid cleaning validation.

In‑line dilution: If the load conductivity is too high (e.g., >8 mS/cm), dilute with WFI or low‑salt buffer using a static mixer and a second pump. This is common when the viral inactivated pool has been neutralized with base.

Fraction collection: To achieve the purity needed for final drug substance, many processes collect the eluate in multiple fractions and pool only the center cut (excluding the front and tail where aggregates elute). Automated fractionation based on UV slope or timed collection is standard.

Step 7.5: Aggregate Removal – The Key Value of CEX

Aggregates are the primary concern after Protein A. They are more immunogenic and can cause adverse reactions. CEX is exceptionally good at separating monomers from aggregates.

Why aggregates behave differently:

• Aggregates often have slightly different surface charge distributions.

• Some aggregates are more hydrophobic and bind more strongly.

• The larger size of aggregates may affect diffusion into resin pores (steric exclusion).

Optimization tips for aggregate removal:

• Use a shallow salt gradient (e.g., 0–300 mM NaCl over 20 CV).

• Consider a pH gradient instead of salt (e.g., pH 5.0 to 8.0) – less common but can be very effective.

• Load at lower density (e.g., 50 g/L instead of 80 g/L) to improve resolution.

• Collect a narrow cut – you may sacrifice 5–10% yield to achieve <0.5% aggregates.

Analytical method: Monitor fractions by SEC‑HPLC to determine which fractions meet the aggregate specification.

Step 7.6: Process Integration – From CEX to Next Step

The CEX eluate (now called CEX Pool) is typically:

• At pH 5.0–5.5, with 150–300 mM NaCl

• mAb concentration 2–10 g/L

• Aggregate level <1% (often <0.5%)

• HCP level reduced to <10 ppm (depending on later steps)

Hold conditions: 2–8°C for up to 24–48 hours before the next polishing step (Anion Exchange or Viral Filtration).

Optional intermediate concentration: Some processes use ultrafiltration/diafiltration (UF/DF) between CEX and AEX to adjust pH and conductivity for the next column. More commonly, the CEX eluate is directly conditioned (diluted or pH adjusted) for AEX.

Step 7.7: What Can Go Wrong? (Troubleshooting)

Step 7.8: Alternatives and Emerging Approaches

• Flow‑through CEX: If the mAb pI is very high (>8.5), you can run CEX in flow‑through mode where the mAb does not bind, but impurities bind. This is simpler but less effective for aggregates.

• Mixed‑mode resins (e.g., Capto MMC): Combine cation exchange with hydrophobic interaction. Can be used as a single polishing step, replacing both CEX and HIC.

• Continuous chromatography (e.g., twin‑column MCSGP): For high‑throughput polishing, but still rare in commercial mAb manufacturing.

For a legacy product like Humira, standard bind‑elute CEX remains the reliable choice.

What Comes Next?

The CEX pool, now low in aggregates and HCPs, moves to the final polishing step: Anion Exchange Chromatography (AEX) . AEX operates in flow‑through mode to remove DNA, endotoxins, and residual viruses. That will be Step 8: Anion Exchange Chromatography – Flow‑Through Polishing.

Questions for our readers:

• What salt gradient do you use for aggregate removal on CEX?

• Have you successfully replaced CEX with a mixed‑mode resin?

Share your experiences below. Next week: Step 8 – Anion Exchange Chromatography.